MyAverix Finance
US · Healthcare
ProQR Therapeutics BV (PRQR)
Biotechnology
ProQR Therapeutics BV (PRQR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PRQR
ProQR Therapeutics BV (PRQR) — FAQ
What is PRQR's P/E ratio?
The price-to-earnings (P/E) ratio for ProQR Therapeutics BV (PRQR) is 25.00 (data as of 2026-05-23).
Does ProQR Therapeutics BV pay a dividend?
Dividend yield is not available in the current snapshot for ProQR Therapeutics BV (PRQR). Check the MyAverix Finance app for the latest dividend data.
What sector is ProQR Therapeutics BV in?
ProQR Therapeutics BV (PRQR) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PRQR listed on?
PRQR is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.